Johnson & Johnson has reported $7.1 billion in worldwide sales of its medical and diagnostic devices for the third quarter, up 12.5 percent compared to the same quarter last year. Sales included the impact of the recently completed acquisition of Synthes, which contributed 14.7 percent to worldwide operational sales growth, net of the divestiture of the DePuy trauma business.
More Articles on Orthopedic Devices:
Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products
Judge Throws Out Most Allegations Against Wright Medical Group
Symmetry Surgical, AMT Electrosurgery Strike Distribution Agreement